Coexpression and coregulation analysis of time-series gene expression data in estrogen-induced breast cancer cell

Algorithms for Molecular Biology

Volumn 8, Issue 1, 2013, Pages

  Bhar, Anirban ^a   Haubrock, Martin ^a   Mukhopadhyay, Anirban ^b   Maulik, Ujjwal ^c   Bandyopadhyay, Sanghamitra ^d   Wingender, Edgar ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF KALYANI   (India)

^c JADAVPUR UNIVERSITY   (India)

^d INDIAN STATISTICAL INSTITUTE   (India)

Author keywords

Affirmation score; Eigengene; Gene ontology; KEGG pathway; Mean squared residue; Time series gene expression data; TRANSFAC; Tricluster

Indexed keywords

EID: 84875173029     PISSN: None     EISSN: 17487188     Source Type: Journal    
DOI: 10.1186/1748-7188-8-9     Document Type: Article

References (46)

1. Maulik U, Mukhopadhyay A, Bandyopadhyay S. Finding multiple coherent biclusters in microarray data using variable string length multiobjective genetic algorithm. IEEE Trans IT Biomed 2009, 13(6):969-975.
2. Cheng Y, Church GM. Biclustering of expression data. Proc Int Conf Intell Syst Mol Biol (ISMB 2000) 2000, 93-103.
3. Zhao L, Zaki MJ. TRICLUSTER: an effective algorithm for mining coherent clusters in 3D microarray data. SIGMOD '05: Proceedings of the 2005 ACM SIGMOD international conference on Management of data 2005 2005, 694-705.
4. Bhar A, Haubrock M, Mukhopadhyay A, Maulik U, Bandyopadhyay S, Wingender E. δ-TRIMAX: extracting triclusters and analysing coregulation in time series gene expression data. Algorithms in Bioinformatics, 12th International Workshop, WABI 2012, Ljubljana, Slovenia, September 10-12, 2012, Proceedings 2012, 165-177. Berlin, Heidelberg: Springer, Raphael B, Tang J.
5. Wolff MS, Collman GW, Barrett JC, Huff J. Breast cancer and environmental risk factors: epidemiological and experimental findings. Annu Rev Pharmacol Toxicol 1996, 36:573-596. 10.1146/annurev.pa.36.040196.003041, 8725402.
6. Mukhopadhyay A, Maulik U, Bandyopadhyay S. A novel coherence measure for discovering scaling biclusters from gene expression data. J Bioinform Comput Biol 2009, 7(5):853-868. 10.1142/S0219720009004370, 19785049.
7. Langfelder P, Horvath S. Eigengene networks for studying the relationships between co-expression modules. BMC Syst Biol 2007, 1:54. 10.1186/1752-0509-1-54, 2267703, 18031580.
8. Prelic A, Bleuler S, Zimmermann P, Wille A, Bhlmann P, Gruissem W, Hennig L, Thiele L, Zitzler E. A systematic comparison and evaluation of biclustering methods for gene expression data. Bioinformatics 2006, 22:1122-1129. 10.1093/bioinformatics/btl060, 16500941.
9. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, FOX EA, Silver PA, Gingeras TR, Liu XS, Brown M. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 2006, 38(11):1289-1297. 10.1038/ng1901, 17013392.
10. Maulik U, Bandyopadhyay S, Mukhopadhyay A. Multiobjective fuzzy biclustering in microarray data: method and a new performance measure. Evolutionary Computation, 2008. CEC 2008. (IEEE World Congress on Computational Intelligence). IEEE Congress on 2008, 1536-1543.
11. Falcon S, Gentleman R. Using GOSTATS to test gene lists for GO term association. Bioinformatics 2007, 23(2):257-258. 10.1093/bioinformatics/btl567, 17098774.
12. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995, 57:289-300.
13. Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res 2007, 9(5):R63. 10.1186/bcr1769, 2242658, 17897439.
14. Maynadier M, Nird P, Ramirez JM, Cathiard AM, Platet N, Chambon M, Garcia M. Role of estrogens and their receptors in adhesion and invasiveness of breast cancer cells. Adv Exp Med Biol 2008, 617:485-491. 10.1007/978-0-387-69080-3_48, 2566989, 18497073.
15. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3(1):1544-6115.
16. Boulay A, Rudloff J, Ye J, Zumstein-Mecker S, O'Reilly T, Evans DB, Chen S, Lane HA. Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer. SIGMOD 2005, 11(14):5319-5328.
17. Chu I, Arnaout A, Loiseau S, Sun J, Seth A, McMahon C, Chun K, Hennessy B, Mills GB, Nawaz Z, Slingerland JM. Src promotes estrogen-dependent estrogen receptor α proteolysis in human breast cancer. J Clin Invest 2007, 117:2205-2215. 10.1172/JCI21739, 1906730, 17627304.
18. Stope M, Popp SL, Knabbe C, Buck MB. Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands. Breast Cancer Res Treat 2010, 120(2):357-367. 10.1007/s10549-009-0393-2, 19370415.
19. Ariazi EA, Cunliffe HE, Lewis-Wambi JS, Slifker MJ, Willis AL, Ramos P, Tapia C, Kim HR, Yerrum S, Sharma CG, Nicolas E, Balagurunathan Y, Ross EA, Jordan VC. Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time. PNAS 2011, 108(47):18879-18886. 10.1073/pnas.1115188108, 3223472, 22011582.
20. Sonne-Hansen K, Norrie IC, Emdal KB, Benjaminsen RV, Frogne T, Christiansen IJ, Kirkegaard T, Lykkesfeldt AE. Breast cancer cells can switch between estrogen receptor alpha and ErbB signaling and combined treatment against both signaling pathways postpones development of resistance. Breast Cancer Res Treat 2010, 121(3):601-613. 10.1007/s10549-009-0506-y, 19697122.
21. Wang HH, Liu M, Clegg DJ, Portincasa P, Wang DQ. New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. Biochimica etBiophysica Acta 2009, 1791(11):1037-1047.
22. Tsuyada A, Chow A, Wu J, Somlo G, Chu P, Loera S, Luu T, Li AX, Wu X, Ye W, Chen S, Zhou W, Yu Y, Wang YZ, Ren X, Li H, Scherle P, Kuroki Y, Wang SE. CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res 2012, 72(11):2768-2779. 10.1158/0008-5472.CAN-11-3567, 22472119.
23. Moon HG, Hwang KT, Kim JA, Kim HS, Lee MJ, Jung EM, Ko E, Han W, Noh DY. NFIB is a potential target for estrogen receptor-negative breast cancers. Mol Oncol 2011, 5(6):538-544. 10.1016/j.molonc.2011.08.002, 21925980.
24. El Hiani Y, Ahidouch A, Lehen'kyi V, Hague F, Gouilleux F, Mentaverri R, Kamel S, Lassoued K, Brl G, Ouadid-Ahidouch H. Extracellular signal-regulated kinases 1 and 2 and TRPC1 channels are required for calcium-sensing receptor-stimulated MCF-7 breast cancer cell proliferation. Cell Physiol Biochem 2009, 23:335-346. 10.1159/000218179, 19471101.
25. Manna PP, Frazier WA. CD47 mediates killing of breast tumor cells via Gi-dependent inhibition of protein kinase A. Cancer Res 2004, 64:1026-1036. 10.1158/0008-5472.CAN-03-1708, 14871834.
26. Lehtinen L, Vainio P, Wikman H, Reemts J, Hilvo M, Issa R, Pollari S, Brandt B, Oresic M, Pantel K, Kallioniemi O, Iljin K. 15-Hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelialmesenchymal transition, and promotes cell migration in cultured breast cancer cells. J Pathol 2012, 226(4):674-686. 10.1002/path.3956, 22072156.
27. Kim SY, Dunn IF, Firestein R, Gupta P, Wardwell L, Repich K, Schinzel AC, Wittner B, Silver SJ, Root DE, Boehm JS, Ramaswamy S, Lander ES, Hahn WC. CK1ε is required for breast cancers dependent on β-Catenin activity. PLOS ONE 2010, 5(2):e8979. 10.1371/journal.pone.0008979, 2813871, 20126544.
28. Favaro E, Lord S, Harris AL, Buffa FM. Gene expression and hypoxia in breast cancer. Genome Med 2011, 3(8):55. 10.1186/gm271, 3238181, 21875443.
29. Crawford NP, Alsarraj J, Lukes L, Walker RC, Officewala JS, Yang HH, Lee MP, Ozato K, Hunter KW. Bromodomain 4 activation predicts breast cancer survival. PNAS 2008, 105(17):6380-6385. 10.1073/pnas.0710331105, 2359777, 18427120.
30. Brough R, Frankum JR, Sims D, Mackay A, Mendes-Pereira A, Bajrami I, Costa-Cabral S, Rafiq R, Ahmad A, Cerone M, Natrajan R, Sharpe R, Shiu KK, Wetterskog D, Dedes KJ, Lambros MB, Rawjee T, Linardopoulos S, Reis-Filho JS, Turner NC, Lord CJ, Ashworth A. Functional viability profiles of breast cancer. Cancer Discov 2011, 1(3):260-273. 10.1158/2159-8290.CD-11-0107, 3188379, 21984977.
31. Li Y, Prasad A, Jia Y, Roy S, Loison F, Mondal S, Kocjan P, Silberstein L, Ding S, Luo H. Pretreatment with phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibitor SF1670 augments the efficacy of granulocyte transfusion in a clinically relevant mouse model. Blood 2011, 117(24):6702-6713. 10.1182/blood-2010-09-309864, 3123029, 21521784.
32. Bekhouche I, Finetti P, Adelade J, Ferrari A, Tarpin C, Charafe-Jauffret E, Charpin C, Houvenaeghel G, Jacquemier J, Bidaut G, Birnbaum D, Viens P, Chaffanet M, Bertucci F. High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes. PLoS One 2011, 6(2):e16950. 10.1371/journal.pone.0016950, 3037286, 21339811.
33. Sieuwerts AM, Meijer-van Gelder ME, Timmermans M, Trapman AM, Garcia RR, Arnold M, Goedheer AJ, Portengen H, Klijn JG, Foekens JA. How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study. Clin Cancer Res 2005, 11(20):7311-7321. 10.1158/1078-0432.CCR-05-0560, 16243802.
34. Kim J, Jahng WJ, Di Vizio D, Lee JS, Jhaveri R, Rubin MA, Shisheva A, Freeman MR. The phosphoinositide kinase PIKfyve mediates epidermal growth factor receptor trafficking to the nucleus. Cancer Res 2007, 67:9229-9237. 10.1158/0008-5472.CAN-07-1333, 17909029.
35. Adrain C, Strisovsky K, Zettl M, Hu L, Lemberg MK, Freeman M. Mammalian EGF receptor activation by the rhomboid protease RHBDL2. EMBO Rep 2011, 12(5):421-427. 10.1038/embor.2011.50, 3090019, 21494248.
36. Wang J, Ray PS, Sim MS, Zhou XZ, Lu KP, Lee AV, Lin X, Bagaria SP, Giuliano AE, Cui X. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NFKB signaling. Oncogene 2012, 31(45):4798-4802. 10.1038/onc.2011.635, 22249250.
37. Wingender E, Chen X, Fricke E, Geffers R, Hehl R, Liebich I, Krull M, Matys V, Michael H, Ohnhuser R, Prss M, Schacherer F, Thiele S, Urbach S. The TRANSFAC system on gene expression regulation. Nucleic Acids Res 2001, 29(29):281-283. 29801, 11125113.
38. Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, Lindblad-Toh K, Lander ES, Kellis M. Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. NATURE 2005, 434(7031):338-345. 10.1038/nature03441, 2923337, 15735639.
39. Boyle EI, Weng S, Gollub J, Jin H, Botstein D, Cherry JM, Sherlock G. GO::TermFinder-open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics 2004, 20(18):3710-3715. 10.1093/bioinformatics/bth456, 3037731, 15297299.
40. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat 2001, 29(4):1165-1188.
41. Stender JD, Frasor J, Komm B, Chang KC, Kraus WL, Katzenellenbogen BS. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation. Mol Endocrinol 2007, 21(9):2112-2123. 10.1210/me.2006-0474, 17550982.
42. Khan S, Wu F, Liu S, Wu Q, Safe S. Role of specificity protein transcription factors in estrogen-induced gene expression in MCF-7 breast cancer cells. J Mol Endocrinol 2007, 39:289-304. 10.1677/JME-07-0043, 17909268.
43. Kim K, Barhoumi R, Burghardt R, Safe S. Analysis of estrogen receptor α-Sp1 interactions in breast cancer cells by fluorescence resonance energy transfer. Mol Endocrinol 2005, 19(4):843-854. 10.1210/me.2004-0326, 15637147.
44. Haakenson JK, Kester M, Liu DX. The ATF/CREB family of transcription factors in breast cancer. Targeting New Pathways and Cell Death in Breast Cancer 2012, Aft RL. InTech.
45. Mancini M, Toker A. NFAT proteins: emerging roles in cancer progression. Nat Rev Cancer 2009, 9(11):810-820. 10.1038/nrc2735, 2866640, 19851316.
46. Wang C, Yu J, Kallen CB. Two estrogen response element sequences near the PCNA gene are not responsible for its estrogen-enhanced expression in MCF7 cells. PLOS ONE 2008, 3(10):e3523. 10.1371/journal.pone.0003523, 2568806, 18949048.